Skip to main content
SpringerLink
Log in

Merck and Co. has announced that the US Centers for Disease Control and Prevention's (CDC's) Advisory Committee on Immunization Practices

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Merck & Co Inc.CDC Advisory Panel Votes to Recommend Merck's Shingles Vaccine, ZOSTAVAX (Rm), for Vaccination of Adults Age 60 and Over. Media Release: 26 Oct 2006. Available from: URL: http://www.merck.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Merck and Co. has announced that the US Centers for Disease Control and Prevention's (CDC's) Advisory Committee on Immunization Practices. Pharmacoecon. Outcomes News 516, 10 (2006). https://doi.org/10.2165/00151234-200605160-00030

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200605160-00030

Keywords

Search

Navigation